Nemat Khan Selected Research

Nemat Khan Research Topics

Disease

6	Neuralgia (Stump Neuralgia) 01/2022 - 11/2014
5	Hyperalgesia 01/2021 - 06/2015
3	Neuroinflammatory Diseases 10/2020 - 11/2014
2	Infections 01/2024 - 01/2021
2	Pain (Aches) 01/2022 - 01/2018
2	Multiple Sclerosis 01/2022 - 02/2018
2	Hypersensitivity (Allergy) 01/2018 - 01/2017
1	Cicatrix (Scar) 03/2024
1	Burns 03/2024
1	Hypocalcemia 03/2024
1	Fever (Fevers) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2024
1	Lung Injury 01/2024
1	Sepsis (Septicemia) 01/2024
1	Myocardial Infarction 12/2023
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	COVID-19 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Low Back Pain (Lumbago) 09/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Cancer Pain 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2015

Drug/Important Bio-Agent (IBA)

3	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2020 - 06/2015
2	Thioctic Acid (Lipoic Acid)IBA 01/2022 - 06/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2019
2	2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA 09/2019 - 01/2018
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 11/2014
1	Vitamin D FDA LinkGeneric 03/2024
1	CalciumIBA 03/2024
1	Eph Family Receptors (Eph Receptors)IBA 01/2024
1	Ephrin-A1 (Ephrin A1)IBA 01/2024
1	Erythropoietin FDA Link 01/2024
1	LigandsIBA 01/2024
1	EphrinsIBA 01/2024
1	Acid Sensing Ion ChannelsIBA 12/2023
1	EstersIBA 01/2022
1	EsterasesIBA 01/2022
1	ProdrugsIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	AntibodiesIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 02/2018
1	NLR ProteinsIBA 02/2018
1	InflammasomesIBA 02/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Diphosphonates (Bisphosphonates)IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Denosumab FDA Link 01/2018
1	somatostatin receptor subtype-4IBA 01/2018
1	WL 19IBA 01/2017
1	Angiotensin IIIBA 01/2017
1	Nerve Growth Factor (NGF)IBA 06/2015
1	Nerve Growth Factors (Neurotrophins)IBA 06/2015
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 06/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015
1	Quil AIBA 11/2014

Therapy/Procedure

1	Ligation 01/2024
1	Punctures 01/2024
1	Therapeutics 06/2015